Guidelines
Home / Guidelines
| Title | Version (Issue) No. | Date of Implementation | Document Link |
|---|---|---|---|
| Guideline for Donation of Medicines and Related Products | 1 | 19 May 2021 |  |
| Guideline for Repackaging and Labelling of Medicines | 3 | 10 July 2020 | |
| Guideline for Registration of Medicines | 3 | 15 April 2020 | |
| Guidance for the Application in the Common Technical Document (CTD) | 2 | 15 April 2020 | |
| Guideline for Import and Export of Medicines and Related Products | 3 | 10 July 2020 | |
| Guidance for Pre-shipment Inspection and Testing of Pharmaceutical Products Exported to The Gambia from India New | 1 | 15 June 2023 | |
| Guideline for Registration of Herbal Medicinal Products | 3 | 15 April 2020 | |
| Guideline for Inspections by the Medicines Control Agency | 2 | 01 July 2020 | |
| Guideline for Storage and Distribution of Medicines and Related Products | 2 | 01 July 2020 | |
| Guideline for Recall of Medicines and Related Products | 2 | 01 July 2020 | |
| Guideline for Safe Disposal of Medicines and Related Products | 2 | 01 July 2020 | |
| Guideline for Advertisement of Medicines and Related Products | 2 | 25 June 2020 | |
| Guideline for Licensing as Importer of Medicines and Related Products | 3 | 10 July 2020 | |
| Guideline for Licensing of Facilities Storing Medicines and Related Products | 1 | 10 July 2020 | |
Guideline for Reporting of Adverse Reactions to Medicines including Vaccines Updated | 2 | 10 December 2021 | |
| Guideline for Safety Monitoring of Medicines (Pharmacovigilance) including Vaccines New | 1 | 10 December 2021 | |
| Guideline for the National Pharmacovigilance System New | 1 | 10 December 2021 | |
| Guideline for Clinical Trials in humans | 2 | 15 February 2021 | |
| Guideline for Emergency Use Authorisation New | 1 | 30 March 2022 | |
| Guideline for Reliance on decisions, reports, or information from other national medicines regulatory authorities (NMRAs) or regional and international bodies New | 1 | 24 January 2022 | |
| Annex I of the Guideline on Reliance: List of Reference Institutions (RIs) New | 1 | 24 January 2022 | |
| Annex II of Guideline on Reliance: Proposed documentation for the abridged authorisation procedure for reference institution (RI)-approved medicines New | 1 | 24 January 2022 | |
| Guidance for Listing of Medicines and Related Products New | 1 | 10 October 2023 | |